Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds
NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer
Two-Point Rise In PSA Signals High-Risk Prostate Cancer
High Cervical Cancer Rates Indicate Access Problems
Lifestyle Changes Common After Cancer Diagnosis
Proton Beam Radiation Helps Cancer Patients Retain Vision
Cooperative Group Trials Approved By NCI Are Listed
Trending Stories
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- ACOG says it will no longer accept federal funding
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death - The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”
